Skip to main content
Actuate Therapeutics, Inc. (ACTU)
Actuate Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$8.00 - $10.00
Shares Offered
5,555,556
Deal Size
$50.00M

Actuate Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20232022
Net Income
-24.74-20.16
Share-Based Compensation
0.420.65
Other Operating Activities
2.71.71
Operating Cash Flow
-21.63-17.79
Share Issuance / Repurchase
4.1319.26
Financing Cash Flow
4.1319.26
Net Cash Flow
-17.491.46
Free Cash Flow
-21.63-17.79
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).